ATP-sensitive potassium channel opener, Nicorandil, inhibits NF-κB/AIM2/GSDMD pathway activation to protect against neuroinflammation in ischemic stroke
- PMID: 39069080
- DOI: 10.1016/j.neuint.2024.105810
ATP-sensitive potassium channel opener, Nicorandil, inhibits NF-κB/AIM2/GSDMD pathway activation to protect against neuroinflammation in ischemic stroke
Abstract
The absent in melanoma 2 (AIM2) inflammasome contributes to ischemic brain injury by inducing cell pyroptosis and inflammatory responses. Our research group has previously demonstrated that ATP-sensitive potassium channels (KATP channels) openers can modulate neuronal synaptic plasticity post-ischemic stroke for neuroprotection. However, the specific mechanisms of KATP channels in the inflammatory response following ischemic stroke remain unclear. Here, we assessed cellular damage by observing changes in BV-2 morphology and viability. 2,3,5-Triphenyl tetrazolium chloride (TTC) staining, mNSS scoring, Nissl staining, and TdT-mediated dUTP nick end labeling (TUNEL) staining were used to evaluate behavioral deficits, brain injury severity, and neuronal damage in mice subjected to middle cerebral artery occlusion (MCAO). Quantitative real-time polymerase chain reaction (qRT-PCR), Western blotting, immunofluorescence, and enzyme-linked immunosorbent assay (ELISA) were used to measure cell pyroptosis and nuclear factor-kappaB (NF-κB) activation in vivo and in vitro. We observed that AIM2 protein expression was upregulated and localized within the cytoplasm of BV-2 cells. Notably, low-dose Nicorandil treatment reduced inflammatory cytokine secretion and pyroptosis-related protein expression, including AIM2, cleaved cysteinyl aspartate-specific protease-1 (cleaved caspase-1), and Gasdermin D N-terminal (GSDMD-NT). Further investigations revealed that the KATP channel inhibitor 5-HD upregulated p-NF-κB p65, NF-κB p65, and p-IκBα expression, reversing Nicorandil's neuroprotective effect in vivo. In summary, our results suggest that Nicorandil may serve as a potential therapeutic option for ischemic stroke. Targeting AIM2 and NF-κB represents effective strategies for inhibiting neuroinflammation.
Keywords: AIM2 inflammasome; ATP-Sensitive potassium channel; NF-κB; Nicorandil; Pyroptosis.
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of competing interest There are no conflict of interest among all authors.
Similar articles
-
Apelin-13 enhances neurofunctional recovery and suppresses neuroinflammation via the SIRT1/NF-κB axis in ischemic stroke.Cell Immunol. 2025 Jul;413:104958. doi: 10.1016/j.cellimm.2025.104958. Epub 2025 Apr 22. Cell Immunol. 2025. PMID: 40378509
-
A novel p55PIK signaling peptide inhibitor alleviates neuroinflammation via the STAT3/NF-kB signaling pathway in experimental stroke.J Stroke Cerebrovasc Dis. 2024 Jul;33(7):107736. doi: 10.1016/j.jstrokecerebrovasdis.2024.107736. Epub 2024 Apr 26. J Stroke Cerebrovasc Dis. 2024. PMID: 38679216
-
STING mediates microglial pyroptosis via interaction with NLRP3 in cerebral ischaemic stroke.Stroke Vasc Neurol. 2024 Apr 30;9(2):153-164. doi: 10.1136/svn-2023-002320. Stroke Vasc Neurol. 2024. PMID: 37402504 Free PMC article.
-
Targeting the gasdermin D as a strategy for ischemic stroke therapy.Biochem Pharmacol. 2021 Jun;188:114585. doi: 10.1016/j.bcp.2021.114585. Epub 2021 Apr 27. Biochem Pharmacol. 2021. PMID: 33930348 Review.
-
Activation of Inflammasomes and Relevant Modulators for the Treatment of Microglia-mediated Neuroinflammation in Ischemic Stroke.Mol Neurobiol. 2024 Dec;61(12):10792-10804. doi: 10.1007/s12035-024-04225-1. Epub 2024 May 24. Mol Neurobiol. 2024. PMID: 38789893 Review.
Cited by
-
Targeting of the PI3 K/AKT/GSK3β Pathway in Parkinson's Disease: A Therapeutic Blueprint.Mol Neurobiol. 2025 Jun 5. doi: 10.1007/s12035-025-05113-y. Online ahead of print. Mol Neurobiol. 2025. PMID: 40474025 Review.
-
Mitochondrial DNA leakage: underlying mechanisms and therapeutic implications in neurological disorders.J Neuroinflammation. 2025 Feb 7;22(1):34. doi: 10.1186/s12974-025-03363-0. J Neuroinflammation. 2025. PMID: 39920753 Free PMC article. Review.
-
Edaravone dexborneol protected neurological function by targeting NRF2/ARE and NF-κB/AIM2 pathways in cerebral ischemia/reperfusion injury.Front Pharmacol. 2025 Apr 25;16:1581320. doi: 10.3389/fphar.2025.1581320. eCollection 2025. Front Pharmacol. 2025. PMID: 40351418 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials